Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-131293
Filing Date
2018-04-25
Accepted
2018-04-25 16:04:56
Documents
6
Period of Report
2018-04-25

Document Format Files

Seq Description Document Type Size
1 6-K d576405d6k.htm 6-K 9741
2 EX-99.1 d576405dex991.htm EX-99.1 112282
3 EX-99.2 d576405dex992.htm EX-99.2 7291
4 GRAPHIC g576405g1.jpg GRAPHIC 12507
5 GRAPHIC g576405nimg001.jpg GRAPHIC 216710
6 GRAPHIC g576405nimg002.jpg GRAPHIC 232380
  Complete submission text file 0001193125-18-131293.txt   766537
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38079 | Film No.: 18774367
SIC: 2834 Pharmaceutical Preparations